Larger Effects of Fenofibrate on CVD in Marked Diabetic Dyslipidemia Are Not Explained by Higher Use of Statin Therapy: The FIELD Study

Larger Effects of Fenofibrate on CVD in Marked Diabetic Dyslipidemia Are Not Explained by Higher Use of Statin Therapy: The FIELD Study

Bibliographic Details
Main Authors:	Simes, R, Voysey, M, O'Connell, R, Glasziou, P, Best, J, Scott, R, Sullivan, DR, Ehnholm, C, Keech, A, Sydney, U
Format:	Conference item
Published:	2009

Similar Items

Effects of Fenofibrate on Cardiovascular (CVD) Events in Patients with Type 2 Diabetes Mellitus (DM) after Adjustment for Statin Use and Other Drugs: the FIELD Study
by: Simes, J, et al.
Published: (2008)

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study.
by: Davis, T, et al.
Published: (2011)

Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481].
by: Scott, R, et al.
Published: (2005)

Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
by: Tonkin, A, et al.
Published: (2012)

A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trials.
by: Simes, J, et al.
Published: (2010)

Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes
by: Januszewski, Andrzej S., et al.
Published: (2021)

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
by: Keech, A, et al.
Published: (2005)

Statins and diabetes - Authors' reply
by: Kearney, P, et al.
Published: (2008)

Statins and diabetes - Reply
by: Kearney, P, et al.
Published: (2008)

Cholesterol and total mortality: need for larger trials.
by: Collins, R, et al.
Published: (1992)

The need for a large-scale trial of fibrate therapy in diabetes: The rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]
by: Barter, P, et al.
Published: (2004)

Fenofibrate and statin therapy, compared with placebo and statin, slows the development of retinopathy in type 2 diabetes patients of 10 years duration: the ACCORD study.
by: Matthews, DR
Published: (2011)

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial.
by: Rajamani, K, et al.
Published: (2009)

Effect of fenofibrate on progression of diabetic retinopathy
by: Preiss, D, et al.
Published: (2024)

Dyslipidemia control and adverse drug reactions of statins among patients at cardiac clinic of Penang Hospital, Malaysia[RS1-441].
by: Alrazzaq, Hadeer Akram Abdul
Published: (2009)

Arterial stiffness and its association with dyslipidemia
by: Mohd Rus, Razman, et al.
Published: (2013)

Confined crystallization of fenofibrate in nanoporous silica
by: Dwyer, Leia Mary, et al.
Published: (2017)

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
by: Mihaylova, B, et al.
Published: (2012)

Common variants at 30 loci contribute to polygenic dyslipidemia.
by: Kathiresan, S, et al.
Published: (2009)

Physical activity, nutrition, and dyslipidemia in middle-aged women
by: Delavar, Mouloud Agajani, et al.
Published: (2011)

LEPTIN GENE POLYMORPHISM IN ISCHEMIC STROKE PATIENTS WITH DYSLIPIDEMIA
by: , EVELYN JEYENTHI ANANTHAM, et al.
Published: (2014)

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
by: Kearney, P, et al.
Published: (2008)

Benefits of reducing LDL cholesterol among 18,686 patients with diabetes: Meta-analysis of 14 radomized trials of a statin versus control
by: Kearney, P, et al.
Published: (2006)

Markerting and the larger construction firm/
by: 353116 Bell, R., et al.
Published: (1981)

Statins for people at low risk of cardiovascular disease reply
by: Mihaylova, B, et al.
Published: (2012)

Preparation And Evaluation Of Fenofibrate-Gelucire 44/14 Solid Dispersions
by: Al-Dhalli, Samer
Published: (2007)

Fenofibrate improves postprandial chylomicron clearance in II B hyperlipoproteinemia.
by: Föger, B, et al.
Published: (1994)

Prediction Of Uncontrolled Dyslipidemia Of Cardiac Outpatients And The Adverse Effect Of Pharmaceutical Excipients
by: Abdulrazzaq, Hadeer Akram
Published: (2013)

Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.
by: Wallace, C, et al.
Published: (2008)

Long-term cardiovascular risks and statin treatment impact on socioeconomic inequalities: microsimulation model
by: Wu, R, et al.
Published: (2023)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
by: Baigent, C, et al.
Published: (2005)

The focalguide to larger format cameras /
by: 386032 Ray, Sidney F.
Published: (1979)

Designing and renovating larger gardens /
by: 253532 Coltart, Douglas
Published: (2007)

Making randomised trials larger: a simple solution?
by: Gray, R, et al.
Published: (1995)

Vascular complications in type 2 diabetes mellitus patients and their association with hypertension and dyslipidemia
by: Khalid, Mohd Khairul Ashraf
Published: (2018)

Insulin resistance, dyslipidemia and the risk of Alzheimer's disease: A case-control study
by: Razay, G, et al.
Published: (2011)

Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study
by: Mihaylova, B, et al.
Published: (2024)

The effect of fenofibrate therapy on laser treatment for diabetic retinopathy: a meta-analysis of randomized controlled trials
by: Preiss, D, et al.
Published: (2021)

Mouse MRI shows brain areas relatively larger in males emerge before those larger in females
by: Qiu, LR, et al.
Published: (2018)

The effectiveness of various salacca vinegars as therapeutic agent for management of hyperglycemia and dyslipidemia on diabetic rats
by: Elok Zubaidah, et al.
Published: (2017)